| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|
| Aug 26, 2015 D VBI VACCINES INC. File 021-246473 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Jun 22, 2015 D LYCERA CORP File 021-242213 | $0 | $0 | $0 (est.) Proceeds from the offering will be used for general working capital. | None listed on this filing | EDGAR ↗ |
| Aug 8, 2014 D VBI VACCINES INC. File 021-222563 | $300,000 | $0 | $1,762,300 (est.) Approximately $1,762,300 of the proceeds from the offering will be used to pay executive officer salaries and board compensation. | Middlebury Securities, LLC BrokerCheck CRD 122602 ↗ | EDGAR ↗ |
| Aug 8, 2014 D VBI VACCINES INC. File 021-222565 | $367,500 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Apr 4, 2014 D LYCERA CORP File 021-214958 | $0 | $0 | $0 (est.) Proceeds from the offering will be used for general working capital. | None listed on this filing | EDGAR ↗ |
| Mar 25, 2014 D Variation Biotechnologies (US), Inc. File 021-214214 | $65,000 | $0 | $250,000 (est.) Approx. $250K in ordinary course compensation and board fees to be paid to named officers and directors. | Middlebury Securities, LLC BrokerCheck CRD 122602 ↗ Palladium Capital Advisors, LLC BrokerCheck CRD 129400 ↗ | EDGAR ↗ |
| Dec 24, 2013 D Variation Biotechnologies (US), Inc. File 021-208713 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 21, 2013 D LYCERA CORP File 021-204965 | $0 | $0 | $0 (est.) Proceeds from the offering will be used for general working capital. | None listed on this filing | EDGAR ↗ |
| Sep 10, 2013 D Variation Biotechnologies (US), Inc. File 021-202580 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 16, 2013 D/A ALLOZYNE INC File 021-194545 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 20, 2013 D Variation Biotechnologies (US), Inc. File 021-198327 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 8, 2013 D Variation Biotechnologies (US), Inc. File 021-192997 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 13, 2012 D TETRALOGIC PHARMACEUTICALS CORP File 021-188311 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 9, 2012 D Variation Biotechnologies (US), Inc. File 021-186732 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 29, 2012 D Variation Biotechnologies (US), Inc. File 021-180572 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 28, 2012 D/A LYCERA CORP File 021-96985 | $0 | $0 | $0 (est.) Proceeds from the offering will be used for general working capital. | None listed on this filing | EDGAR ↗ |
| Jun 1, 2012 D ALLOZYNE INC File 021-179144 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 18, 2012 D ALLOZYNE INC File 021-178473 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 10, 2012 D Variation Biotechnologies (US), Inc. File 021-173278 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 3, 2012 D ALLOZYNE INC File 021-172873 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 14, 2011 D/A Virdante Pharmaceuticals, Inc. File 021-114968 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 31, 2011 D TETRALOGIC PHARMACEUTICALS CORP File 021-160530 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 31, 2011 D MACROGENICS INC File 021-154617 | $0 | $0 | $0 The proceeds from the offering will be used for general working capital purposes. | None listed on this filing | EDGAR ↗ |
| Aug 10, 2010 D TETRALOGIC PHARMACEUTICALS CORP File 021-146152 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |